Research Articles
Aptamer-Conjugated Nanoparticles: The Future of Targeted Cancer Therapy
Explore how aptamer-conjugated nanoparticles are revolutionizing cancer treatment through precise targeted drug delivery with minimal side effects.
G-Quadruplexes: The DNA Knots That Could Unlock Future Cancer Therapy
Explore how G-quadruplex DNA structures are revolutionizing cancer therapy through targeted drug delivery systems and precision medicine approaches.
Platelet-Derived Extracellular Vesicles: Nature's Tiny Messengers in the Fight Against Cancer
Explore how platelet-derived extracellular vesicles (PEVs) are revolutionizing cancer diagnosis and therapy through targeted drug delivery and liquid biopsy applications.
Adipocyte-Based Cell Therapy in Oncology
Exploring how fat cells are being reimagined as drug delivery platforms for cancer treatment
Harnessing Nature's Shield: How Irradiated Chitosan Nanoparticles Are Revolutionizing Cancer Therapy
Exploring the potential of irradiated chitosan nanocomplexes for microRNA delivery in cancer therapy - a breakthrough in nanomedicine
The Comeback Kid: An Old Drug's New Fight Against Disease
Discover how sulphonamides, once-forgotten antibiotics, are being repurposed to fight cancer, autoimmune disorders, and antibiotic-resistant superbugs.
Diamonds in Shrimp Viruses: Unlocking the Anti-Cancer Potential of ICP11 Protein
Discover how the ICP11 protein from shrimp white spot syndrome virus shows promising anti-cancer potential through DNA mimicry mechanism
Silencing Cancer: How Dual-Targeted Nanoparticles Are Revolutionizing Tumor Therapy
Explore how dual-ligand-functionalized curdlan nanoparticles deliver CpG and siRNA for revolutionary cancer therapy.
ATAP Peptides: The Mitochondrial Assassins Revolutionizing Cancer Therapy
Explore how ATAP peptides are transforming cancer treatment through targeted mitochondrial therapy and precision engineering.
Rewriting Cancer's Survival Code: The BCL-2 Family Breakthrough
Discover how BCL-2 protein family research is leading to groundbreaking cancer therapies that trigger cancer cell self-destruction while sparing healthy cells.